Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Adaptive, Multicenter, Randomized, Open-label, Comparative Clinical Study to Assess Efficacy and Safety of Favipiravir in Hospitalized Patients With COVID-19

NCT04434248 is registered in ClinicalTrials.gov with Chromis LLC as lead sponsor.

NCT NCT04434248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04434248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Adaptive, Multicenter, Randomized, Open-label, Comparative Clinical Study to Assess Efficacy and Safety of Favipiravir in Hospitalized Patients With COVID-19
Lead sponsor
Chromis LLC
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 23, 2020
Completion date
July 31, 2020
Enrollment
330 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19